Elsevier and Jisc agree three-year read and publish agreement for UK institutions

LONDON, Feb. 23, 2026 /PRNewswire/ -- Elsevier, a global leader in advanced information and decision support in science and healthcare, today announces a three-year combined read and publish agreement with Jisc - the negotiating body representing UK academic research institutions. The agreement provides participating UK institutions with continued access to Elsevier journals and enables eligible authors to publish open access in Elsevier journals.

Through Elsevier's ongoing partnership with Jisc, the agreement supports UK academic research institutions by combining reading access with open access publishing options, delivering the following benefits for participating institutions:

William Rubens, Regional Vice President, Research Sales at Elsevier, said: "We are pleased to continue working with Jisc in support of the UK's world-class research community. At a time when institutions are managing a range of pressures, this agreement recognises the importance of providing researchers with clear routes to immediate open access, alongside continued access to high-quality, trusted research published in Elsevier journals. Our partnership with Jisc is central to developing approaches that respond to the needs of institutions and support the research community as a whole."

Anna Vernon, Head of Research Licensing, Jisc, added: "This agreement underscores our commitment to supporting the UK's research community at a time of significant pressure. Through bringing the sector together in these agreements we reduce costs and remove administrative burdens for institutions and researchers. Our partnership with Elsevier is another step towards meeting the evolving needs of institutions and strengthening the UK's open research landscape."

Partnership for the Long Term

This agreement forms part of Elsevier's broader engagement with universities, funders, and sector organisations to support open research and responsible publishing. Elsevier continues to work with partners to evolve publishing arrangements that meet the needs of the research community and maintain access to trusted scholarly content.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.

Logo - https://mma.prnewswire.com/media/2717688/5816459/Elsevier_Limited_Logo.jpg

SOURCE Elsevier Limited